Report cover image

Tissue Regenerative Materials Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update

Publisher GlobalData
Published Jun 20, 2022
Length 50 Pages
SKU # GBDT17342750

Description

Tissue Regenerative Materials Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update

Summary

GlobalData's Medical Devices sector report, “Tissue Regenerative Materials Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update provides comprehensive information about the Tissue Regenerative Materials pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Tissue Regenerative Material is a biomaterial component which facilitates regeneration of lost periodontal hard and soft tissue.

Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Tissue Regenerative Materials under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Tissue Regenerative Materials and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to-
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Tissue Regenerative Materials under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

50 Pages
2 Table of Contents
1 About GlobalData
2 Table of Contents
2.1 List of Tables
2.2 List of Figures
3 Introduction
3.1 Tissue Regenerative Materials Overview
4 Products under Development
4.1 Tissue Regenerative Materials - Pipeline Products by Stage of Development
4.2 Tissue Regenerative Materials - Pipeline Products by Territory
4.3 Tissue Regenerative Materials - Pipeline Products by Regulatory Path
4.4 Tissue Regenerative Materials - Pipeline Products by Estimated Approval Date
4.5 Tissue Regenerative Materials - Ongoing Clinical Trials
5 Tissue Regenerative Materials - Pipeline Products under Development by Companies
5.1 Tissue Regenerative Materials Companies - Pipeline Products by Stage of Development
5.2 Tissue Regenerative Materials – Companies Pipeline Products by Stage of Development
6 Tissue Regenerative Materials Companies and Product Overview
6.1 Advanced Biotech Products Pvt Ltd Company Overview
6.1.1 Advanced Biotech Products Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.2 Colorado Therapeutics, LLC Company Overview
6.2.1 Colorado Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview
6.3 credentis AG Company Overview
6.3.1 credentis AG Pipeline Products & Ongoing Clinical Trials Overview
6.4 Histocell SL Company Overview
6.4.1 Histocell SL Pipeline Products & Ongoing Clinical Trials Overview
6.5 Indian Institute of Technology Bombay Company Overview
6.5.1 Indian Institute of Technology Bombay Pipeline Products & Ongoing Clinical Trials Overview
6.6 Maxigen Biotech Inc Company Overview
6.6.1 Maxigen Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview
6.7 Medtronic Plc Company Overview
6.7.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview
6.8 Nobel Biocare Services AG Company Overview
6.8.1 Nobel Biocare Services AG Pipeline Products & Ongoing Clinical Trials Overview
6.9 Novatissue SAS Company Overview
6.9.1 Novatissue SAS Pipeline Products & Ongoing Clinical Trials Overview
6.10 Orthocell Ltd Company Overview
6.10.1 Orthocell Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.11 Orthorebirth Co Ltd Company Overview
6.11.1 Orthorebirth Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.12 Polytechnic University of Catalonia Company Overview
6.12.1 Polytechnic University of Catalonia Pipeline Products & Ongoing Clinical Trials Overview
6.13 Straumann Holding AG Company Overview
6.13.1 Straumann Holding AG Pipeline Products & Ongoing Clinical Trials Overview
6.14 SurgaColl Technologies Ltd Company Overview
6.14.1 SurgaColl Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.15 SweetBio, Inc. Company Overview
6.15.1 SweetBio, Inc. Pipeline Products & Ongoing Clinical Trials Overview
6.16 Tetratherix Pty Ltd Company Overview
6.16.1 Tetratherix Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.17 Tigran Technologies AB Company Overview
6.17.1 Tigran Technologies AB Pipeline Products & Ongoing Clinical Trials Overview
7 Tissue Regenerative Materials- Recent Developments
7.1 May 26, 2022: CollPlant Biotechnologies Provides Business Updates and First Quarter 2022 Financial Results
7.2 Apr 13, 2022: CollPlant To Present at the Aesthetics Innovation Summit 2022
7.3 Mar 24, 2022: CollPlant Biotechnologies Provides Business Updates and Fiscal Year 2021 Financial Results
7.4 Feb 15, 2022: Straumann Group reports revenue exceeding CHF 2 billion
7.5 Feb 04, 2022: Straumann Group announces invitation for 2021 full-year financial results webcast
7.6 Jan 25, 2022: Medprin Regenerative Medical Technologies Announces on the resignation of the company's director and board secretary
7.7 Jan 07, 2022: Collagen Matrix Names Tony Orsini Chief Operating Officer
7.8 Dec 21, 2021: Maipu Medical Announcement on Appointment of Deputy General Manager of the Company
7.9 Nov 18, 2021: CollPlant Biotechnologies Provides Business Updates and Third Quarter 2021 Financial Results
7.10 Oct 18, 2021: Straumann Group 2021 third-quarter financial results webcast invitation
7.11 Aug 19, 2021: CollPlant Biotechnologies Provides Business Updates and Second Quarter 2021 Financial Results
7.12 Jul 29, 2021: Invitation: Straumann Group 2021 half-year financial results webcast
7.13 Jul 15, 2021: Christian Ullrich joins Straumann Group’s Executive Management Board as the new Group Chief Information Officer
8 Appendix
8.1 Methodology
8.2 About GlobalData
8.3 Contact Us
8.4 Disclaimer
2.1 List of Tables
Table 1: Tissue Regenerative Materials - Pipeline Products by Stage of Development
Table 2: Tissue Regenerative Materials - Pipeline Products by Territory
Table 3: Tissue Regenerative Materials - Pipeline Products by Regulatory Path
Table 4: Tissue Regenerative Materials - Pipeline Products by Estimated Approval Date
Table 5: Tissue Regenerative Materials - Ongoing Clinical Trials
Table 6: Tissue Regenerative Materials Companies - Pipeline Products by Stage of Development
Table 7: Tissue Regenerative Materials – Companies Pipeline Products by Stage of Development
Table 8: Advanced Biotech Products Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 9: Healiguide - Product Status
Table 10: Healiguide - Product Description
Table 11: Osseograft - Product Status
Table 12: Osseograft - Product Description
Table 13: Osseomold - Product Status
Table 14: Osseomold - Product Description
Table 15: Colorado Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 16: Xenograft Implant - Dental - Product Status
Table 17: Xenograft Implant - Dental - Product Description
Table 18: credentis AG Pipeline Products & Ongoing Clinical Trials Overview
Table 19: CUROLOX Perio - Product Status
Table 20: CUROLOX Perio - Product Description
Table 21: Histocell SL Pipeline Products & Ongoing Clinical Trials Overview
Table 22: HR018-Neofibrin - Product Status
Table 23: HR018-Neofibrin - Product Description
Table 24: Indian Institute of Technology Bombay Pipeline Products & Ongoing Clinical Trials Overview
Table 25: Electrospun Scaffold - Product Status
Table 26: Electrospun Scaffold - Product Description
Table 27: Maxigen Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 28: MaxiGuide - Product Status
Table 29: MaxiGuide - Product Description
Table 30: Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview
Table 31: MD08 - Product Status
Table 32: MD08 - Product Description
Table 33: Nobel Biocare Services AG Pipeline Products & Ongoing Clinical Trials Overview
Table 34: Bone Inductive Implant - Product Status
Table 35: Bone Inductive Implant - Product Description
Table 36: Novatissue SAS Pipeline Products & Ongoing Clinical Trials Overview
Table 37: OrthoNovaOss - Product Status
Table 38: OrthoNovaOss - Product Description
Table 39: Orthocell Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 40: Striate+ - Product Status
Table 41: Striate+ - Product Description
Table 42: Orthorebirth Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 43: GCT-101 - Product Status
Table 44: GCT-101 - Product Description
Table 45: Polytechnic University of Catalonia Pipeline Products & Ongoing Clinical Trials Overview
Table 46: Inorganic Dental Cement - Product Status
Table 47: Inorganic Dental Cement - Product Description
Table 48: Straumann Holding AG Pipeline Products & Ongoing Clinical Trials Overview
Table 49: Soft Tissue Control Implant - Product Status
Table 50: Soft Tissue Control Implant - Product Description
Table 51: SurgaColl Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 52: DentaColl - Product Status
Table 53: DentaColl - Product Description
Table 54: SweetBio, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 55: SweetBio GTR (Guided Tissue Regeneration) Membrane - Product Status
Table 56: SweetBio GTR (Guided Tissue Regeneration) Membrane - Product Description
Table 57: Tetratherix Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 58: Tetramax - Product Status
Table 59: Tetramax - Product Description
Table 60: Tetratherix Pty Ltd - Ongoing Clinical Trials Overview
Table 61: Tetramax - PET-B: Post Extraction Use of TetraMax Part B (TMB).. A Comparator Controlled Clinical Investigation Comparing the Bone Healing Capability of the Investigational Product TetraMax Plus BioOss and the Gold Standard Standard of Care Comparator BioOssCollagen (BioOssCol), for Adults Who Have Been Treatment Planned for Tooth Extraction/s and Implant Placement at the Same Extraction Site/s
Table 62: Tigran Technologies AB Pipeline Products & Ongoing Clinical Trials Overview
Table 63: Tigran Porous Titanium Granules - Alveolar Fillings - Product Status
Table 64: Tigran Porous Titanium Granules - Alveolar Fillings - Product Description
Table 65: Glossary
2.2 List of Figures
Figure 1: Tissue Regenerative Materials - Pipeline Products by Stage of Development
Figure 2: Tissue Regenerative Materials - Pipeline Products by Territory
Figure 3: Tissue Regenerative Materials - Pipeline Products by Regulatory Path
Figure 4: Tissue Regenerative Materials - Pipeline Products by Estimated Approval Date
Figure 5: Tissue Regenerative Materials - Ongoing Clinical Trials

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us